DILI risk screening at 0.989 AUROC.

96 public test compounds · identity, fingerprint and scaffold references excluded. The identity/fingerprint-only policy scores 0.952 on the same cases.

Strong DILI performance for compound prioritization.

0.989

AUROC · scaffold-reference exclusions

Identity, fingerprint and test-scaffold references excluded. All 96 public test compounds scored.

0.952

AUROC · identity/fingerprint exclusions

The alternative reference policy on the same 96 public test compounds. All cases scored.

Both policies score all 96 public test compounds with the complete DILI system.

Reference policies

EvaluationAUROCCoverage
Identities and identical fingerprints excluded0.95296/96 cases scored; zero exact clinical self-anchors.
Additional test-scaffold exclusions0.989The same 96/96 cases scored. This is a second policy on the same known public test.

Outputs available

OutputUse
DILI risk score and classPrioritize compounds for follow-up testing.
Mechanism contextInspect the chemical and biological factors associated with a returned risk estimate.
Exposure and dose contextEvaluate the specified exposure scenario alongside the risk output.

Evaluation scope

The AUROC measurements evaluate binary risk discrimination in the stated cohort. Mechanism attribution and exposure scenarios have their own validation scope. A frozen product and newly selected partner cases can test performance for your application.

See all current ADMET endpoint measurements.

Evaluate FluxMateria for your application

Choose the properties, input conditions and scoring criteria for your application. A frozen system and partner-selected cases provide a direct product evaluation.

Request access Explore benchmarks